Close
Digital Health & Ai Innovation summit 2026
APE 2026

Holmusk Partners with Streamline Healthcare Solutions

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

FDA May Scrutinize Medical Device Cybersecurity...

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare...

Pristina Recon DL tool from GE HealthCare which uses...

Abbott to Acquire Cancer Test Maker...

In a recent move, Abbott has gone ahead and...

Holmusk recently made an announcement about its partnership with Streamline Healthcare Solutions, with the aim of leveraging advanced analytics to enhance care delivery.

Through this ongoing partnership with Streamline Healthcare Solutions, as well as the new collaboration with Mental Health Partners, Holmusk expands the presence of MaST in the United States.

MaST, the Management and Supervision Tool developed by Holmusk, is an advanced software platform designed to assist healthcare professionals in making informed decisions. It utilises predictive analytics to support decision-making processes, particularly in prioritising individuals who may be at risk of a mental health crisis.

The tool rapidly identify clinically relevant information from patient electronic health records (EHRs) at a speed surpassing human capacity. MaST empowers providers to make more accurate decisions regarding resource allocation. Through the utilisation of MaST, healthcare professionals can leverage predictive analytics to improve decision-making, leading to more effective care delivery.

 

Latest stories

Related stories

FDA May Scrutinize Medical Device Cybersecurity More in 2026

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare Receives a PMA

Pristina Recon DL tool from GE HealthCare which uses...

Abbott to Acquire Cancer Test Maker for Around $21 Billion

In a recent move, Abbott has gone ahead and...

New Policy to Boost Medical Device Industry in China

Beijing has gone on to release a new policy...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »